Back to search
FDAFDA · Food and drugs·Recall number D-0804-2016

Formula 9 (Papaverine 0.9 mg, Phentolamine 0.1 mg, Atropine 0.01 mg, PGE 20 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102.

Published April 13, 2016 · Recall initiated: March 14, 2016

Summary

FDA records drug Class II recall D-0804-2016, published April 13, 2016 and initiated March 14, 2016. Recalling firm: Meditech Laboratories, Inc; Status: Terminated; Reported quantity: 1320 vials - all formulas; Lot: Lot#: 022416-9, Exp 04/09/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: incomplete or missing data regarding production.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Meditech Laboratories, Inc
Distributor
Nationwide
Lot
Lot#: 022416-9, Exp 04/09/16.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Formula 9 (Papaverine 0.9 mg, Phentolamine 0.1 mg, Atropine 0.01 mg, PGE 20 mcg/mL) Injection, 5 mL vial, Rx only, Meditech Laboratories, Inc., 3200 Polaris Ave., Suite 27, Las Vegas, NV 89102. recalled?

Yes. FDA published recall D-0804-2016 on April 13, 2016. Reported hazard: Lack of Assurance of Sterility: incomplete or missing data regarding production.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit